A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
PHASE3
This two-arm, randomized, open-label, multicenter study will evaluate the e...
Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer to Evaluate Treatment With Trastuzumab Plus (+) Pertuzumab + Docetaxel Compared With Trastuzumab + Placebo + Docetaxel
PHASE3
This is an Asia-Pacific regional, randomized, double-blind, multicenter tri...
Status
Completed
Location
The Affiliated Hospital of Military Medical Sciences(The 307th Hospital of Chinese PLA)
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
PHASE3
In this open-label multicenter trial, participants with operable or locally...
Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction
PHASE3
The main clinical goal of NAC is to down-stage the primary tumor for BCS,ye...